Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Genetics, Toxicity, and Distribution of Enterohemorrhagic Escherichia coli Hemolysin.

Schwidder M, Heinisch L, Schmidt H.

Toxins (Basel). 2019 Aug 29;11(9). pii: E502. doi: 10.3390/toxins11090502. Review.

2.

Transcription of the Subtilase Cytotoxin Gene subAB 1 in Shiga Toxin-Producing Escherichia coli Is Dependent on hfq and hns.

Heinisch L, Zoric K, Krause M, Schmidt H.

Appl Environ Microbiol. 2019 Oct 1;85(20). pii: e01281-19. doi: 10.1128/AEM.01281-19. Print 2019 Oct 15.

PMID:
31375495
3.

New S-benzylisothiosemicarbazones with antimycobacterial activity.

Petrlíková E, Waisser K, Heinisch L, Stolaříková J.

Folia Microbiol (Praha). 2011 Jan;56(1):10-2. doi: 10.1007/s12223-011-0015-3. Epub 2011 Mar 11.

PMID:
21394476
4.

Siderophores as drug delivery agents: application of the "Trojan Horse" strategy.

Möllmann U, Heinisch L, Bauernfeind A, Köhler T, Ankel-Fuchs D.

Biometals. 2009 Aug;22(4):615-24. doi: 10.1007/s10534-009-9219-2. Epub 2009 Feb 12.

PMID:
19214755
5.

Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.

Marchand C, Beutler JA, Wamiru A, Budihas S, Möllmann U, Heinisch L, Mellors JW, Le Grice SF, Pommier Y.

Antimicrob Agents Chemother. 2008 Jan;52(1):361-4. Epub 2007 Oct 29.

6.

New antimycobacterial 2,3-dihydro-1-alkylindole-2-thiones.

Waisser K, Heinisch L, Slosárek M, Janota J.

Folia Microbiol (Praha). 2006;51(1):25-6.

PMID:
16821707
7.

New antimycobacterial S-alkylisothiosemicarbazones.

Waisser K, Heinisch L, Slosárek M, Janota J.

Folia Microbiol (Praha). 2005;50(6):479-81.

PMID:
16681143
8.

The Pseudomonas aeruginosa pirA gene encodes a second receptor for ferrienterobactin and synthetic catecholate analogues.

Ghysels B, Ochsner U, Möllman U, Heinisch L, Vasil M, Cornelis P, Matthijs S.

FEMS Microbiol Lett. 2005 May 15;246(2):167-74.

9.

Catecholates and mixed catecholate hydroxamates as artificial siderophores for mycobacteria.

Wittmann S, Heinisch L, Scherlitz-Hofmann I, Stoiber T, Ankel-Fuchs D, Möllmann U.

Biometals. 2004 Feb;17(1):53-64.

PMID:
14977362
10.

Trishydroxamates and triscatecholates based on monosaccharides and myo-inositol as artificial siderophores.

Heggemann S, Möllmann U, Gebhardt P, Heinisch L.

Biometals. 2003 Dec;16(4):539-51.

PMID:
12779239
11.

Synthesis and biological activity of tris- and tetrakiscatecholate siderophores based on poly-aza alkanoic acids or alkylbenzoic acids and their conjugates with beta-lactam antibiotics.

Heinisch L, Wittmann S, Stoiber T, Scherlitz-Hofmann I, Ankel-Fuchs D, Möllmann U.

Arzneimittelforschung. 2003;53(3):188-95.

PMID:
12705174
12.

Prospective assessment of different indices of cardiac risk for patients undergoing noncardiac surgeries.

Heinisch RH, Barbieri CF, Nunes Filho JR, Oliveira GL, Heinisch LM.

Arq Bras Cardiol. 2002 Oct;79(4):327-38. English, Portuguese.

13.

Highly antibacterial active aminoacyl penicillin conjugates with acylated bis-catecholate siderophores based on secondary diamino acids and related compounds.

Heinisch L, Wittmann S, Stoiber T, Berg A, Ankel-Fuchs D, Möllmann U.

J Med Chem. 2002 Jul 4;45(14):3032-40.

PMID:
12086488
14.

New synthetic catecholate-type siderophores with triamine backbone.

Heinisch L, Gebhardt P, Heidersbach R, Reissbrodt R, Möllmann U.

Biometals. 2002 Jun;15(2):133-44.

PMID:
12046921
15.

Effects of synthetic siderophores on proliferation of Plasmodium falciparum in infected human erythrocytes.

Rotheneder A, Fritsche G, Heinisch L, Möllmann U, Heggemann S, Larcher C, Weiss G.

Antimicrob Agents Chemother. 2002 Jun;46(6):2010-3.

16.

A novel type of nonsteroidal estrone sulfatase inhibitors.

Jütten P, Schumann W, Härtl A, Heinisch L, Gräfe U, Werner W, Ulbricht H.

Bioorg Med Chem Lett. 2002 May 20;12(10):1339-42.

PMID:
11992772
17.

New synthetic siderophores and their beta-lactam conjugates based on diamino acids and dipeptides.

Wittmann S, Schnabelrauch M, Scherlitz-Hofmann I, Möllmann U, Ankel-Fuchs D, Heinisch L.

Bioorg Med Chem. 2002 Jun;10(6):1659-70.

PMID:
11937324
19.

New artificial siderophores based on a monosaccharide scaffold.

Heggemann S, Schnabelrauch M, Klemm D, Möllmann U, Reissbrodt R, Heinisch L.

Biometals. 2001 Mar;14(1):1-11.

PMID:
11368270
20.

New synthetic catecholate-type siderophores based on amino acids and dipeptides.

Schnabelrauch M, Wittmann S, Rahn K, Möllmann U, Reissbrodt R, Heinisch L.

Biometals. 2000 Dec;13(4):333-48.

PMID:
11247040
21.

Frequency of headache in the medical students of Santa Catarina's Federal University.

da Costa MZ, Soares CB, Heinisch LM, Heinisch RH.

Headache. 2000 Oct;40(9):740-4.

PMID:
11091293
22.

8-Acyloxy-1,3-benzoxazine-2,4-diones as siderophore components for antibiotics.

Wittmann S, Scherlitz-Hofmann I, Möllmann U, Ankel-Fuchs D, Heinisch L.

Arzneimittelforschung. 2000 Aug;50(8):752-7.

PMID:
10994160
23.

Semisynthetic derivatives of madurahydroxylactone and their antibacterial activities.

Heinisch L, Roemer E, Jütten P, Haas W, Werner W, Möllmann U.

J Antibiot (Tokyo). 1999 Nov;52(11):1029-41.

24.

Novel catecholate-type siderophore analogs based on a myo-inositol scaffold.

Schnabelrauch M, Egbe DA, Heinisch L, Reissbrodt R, Möllmann U.

Biometals. 1998 Sep;11(3):243-51.

PMID:
9850568
25.

[Synthesis and antibacterial action of new ureido- and dicarboxylic acid diamido- derivatives of acylpenicillins with and without catechol substituents].

Heinisch L, Möllmann U, Tresselt D, Willitzer H.

Arzneimittelforschung. 1994 Mar;44(3):349-54. German.

PMID:
8192701
26.

[Relationship between chemical structure and toxicologic-pharmacokinetic properties of new ampicillin derivatives].

Willitzer H, Horn U, Heinisch L, Möllmann U, Hanschke KG, Stengel K, Eckardt K.

Pharmazie. 1992 Jul;47(7):529-30. German.

PMID:
1518899
27.

[New ampicillin derivatives with glyoxyloylbenzhydrazone side chains].

Heinisch L, Hanschke KG, Willitzer H, Möllmann U, Tresselt D, Stengel K, Eckardt K, Kleinwächter W.

Pharmazie. 1992 Jun;47(6):412-5. German.

PMID:
1409839
28.

[Synthesis and antibacterial activity of benzoylaminoacyl-penicillins and related compounds with and without acylated catechol substituents].

Heinisch L, Ulbricht H, Willitzer H, Hanschke KG, Tresselt D, Möllmann U, Eckardt K, Haupt I.

Arzneimittelforschung. 1992 May;42(5):668-73. German.

PMID:
1530682
29.

[Parkinson disease induced by flunarizine].

de Sá PN, Heinisch LM.

Arq Neuropsiquiatr. 1989 Dec;47(4):471-3. Portuguese.

PMID:
2634389
30.
31.
32.
33.

[Synthesis and antimicrobial effect of a heterocyclic isothiosemicarbazone (proceedings)].

Heinisch L, Tonew M, Tonew E, Jakob HE.

Pharmazie. 1979 May-Jun;34(5-6):292. German. No abstract available.

PMID:
515123
34.

[Synthesis and antiviral effect of N-heterocyclic formylisothiosemicarbazones].

Heinisch L, Tonew M, Tonew E.

Pharmazie. 1977 Dec;32(12):752-6. German. No abstract available.

PMID:
206916
35.

[Complex formation of antiviral isatin-3-isothiosemicarbazones and thiocarbonylhydrazones using transition-group metals].

Heinisch L, Tresselt D.

Pharmazie. 1977 Oct;32(10):582-6. German. No abstract available.

PMID:
607216
36.

[Effect of substituted isatinisothiosemicarbazones on the multiplication of bacteria].

Jacob HE, Heinisch L.

Z Allg Mikrobiol. 1977;17(8):647-50. German. No abstract available.

PMID:
416604
37.

[Antiviral isatin-3-thiocarbonylhydrazones and -isothiosemicarbazones and related compounds].

Heinisch L, Tonew M.

Pharmazie. 1976;31(12):840-5. German. No abstract available.

PMID:
1023259
39.

[Virus inhibition in vitro by semioxamazide derivatives].

Heinisch L, Küchler C, Küchler W.

Arzneimittelforschung. 1968 Oct;18(10):1324-8. German. No abstract available.

PMID:
4974422
40.

[Virus inhibition in vitro by 6-azalumazine].

Küchler C, Küchler W, Heinisch L.

Arzneimittelforschung. 1966 Aug;16(8):1122-3. German. No abstract available.

PMID:
6014906

Supplemental Content

Loading ...
Support Center